
Keywords: AHR, aryl hydrocarbon receptor; AML, acute myeloid leukemia; AMPK, AMP-activated protein kinase; AR, androgen receptor; ATR, ataxia telangiectasia and Rad3 related; ββ-BHC, ββ-benzene hexachloride; BMP, bone morphogenetic protein; CDK, cyclin-dependent ki